Skip to content

Comparison of different enteroscope-assisted of ERCP in choliopancreatic disease

Comparison of different enteroscope-assisted of ERCP in choliopancreatic disease

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082352
Enrollment
Unknown
Registered
2024-03-27
Start date
2024-03-29
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Choleopancreatic disease

Interventions

Control group:Co2 exchange
Control group:Water exchange

Sponsors

First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Age: 18-85 years old; (2) Biliopancreatic disease requiring enteroscope-assisted ERCP intervention; (3) The patient agrees the informed consent to participate in the study and signed the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Age 85 years; (2). Severe comorbidities; (3). Acute cholangitis (moderate to severe); (4). Acute stage of acute biliary pancreatitis is a non-convalescent period; (5). Pregnant or lactating women; (6). No stopping anticoagulant; (7). Failed reaching Main papilla of the duodenum.

Design outcomes

Primary

MeasureTime frame
Inset efficiency;

Secondary

MeasureTime frame
Mirror insertion success rate;

Countries

China

Contacts

Public ContactQiao Mei

First Affiliated Hospital of Anhui Medical University

meiqiao@hotmail.com+86 551 6590 8791

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026